Department of Pathology

Dalhousie University

Richard Wood, MD FRCPC

Assistant Professor

PATH-BioDefault-500-Black-NoShield
Department of Pathology

Email: richard.wood@nshealth.ca
Mailing Address: 
Mackenzie Building Room 223A 5788 University Avenue Halifax, NS B3H 1V8
 
Research Topics:
  • Biomarker testing in hematologic and non-hematologic malignancy
  • Haematolymphoid malignancy
  • Inflammatory lymphadenopathies
  • Quality improvement and laboratory efficiency

Biography

Dr. Rick Wood is a practicing diagnostic and clinical pathologist at the QEII Health Sciences Centre, subspecializing in haematolymphoid pathology. He is involved with undergraduate and post-graduate clinical and non-clinical education in the Department of Pathology.

Education

  • BSc Hon: University of New Brunswick, Saint John NB
  • MD: Dalhousie University, Saint John NB
  • Diagnostic and Clinical Pathology Residency: Dalhousie University, Halifax NS
  • Fellowship in Hematologic Pathology: Dalhousie University, Halifax NS

Selected Publications

  1.  *Wood, R. K., *Elsharawi, I.E., Goudie, M., *Bruyere, H., *Rahmani, M., *Gillan, T. L. 2025. The ABCs of IGHV testing in chronic lymphocytic leukemia: Current recommendations, ongoing challenges, and future directions. International Journal of Laboratory Haematology, 1-10.
  2. Schwarzkopf, R., Chen, A.A.Y., Varghese, J., Roberts, J., Wood, R.K., Chen, L.Y.C. 2025. Treatment of severe refractory immune neutropenia with ruxolitinib: Two cases. Journal of Human Immunity, 1(4), e20250131.
  3. Blommers, M., Selegean, S., Wood, R. K., Sarmiento Bustamante, M., Shyamsundar, S., Wiley, E. A., Comeau, E., Shawwa, A. A., Rose-John, S., Fajgenbaum, D. C., & Chen, L. Y. C. 2024. Idiopathic multicentric Castleman disease with marrow fibrosis and extramedullary hematopoiesis. European Journal of Haematology, 113(6), 833–841.
  4. Levesque, M., Wood, R. K., Carter, M. D., Brock, J., Keiser, K. 2023. Screening and testing practices for Lynch syndrome in Nova Scotians with endometrial cancer: a descriptive study. CMAJ Open 11(5), E1012-E1019.
  5. Wood, R. K., Rayson, D., Arnason, T., DeCoste, R., Gaston, D., Carter, M. D. 2022. Complete response of a colonic high-grade neuroendocrine carcinoma to platinum-based therapy: Insights from comprehensive genomic profiling. Canadian Journal of Pathology 14(3), 36-44.
  6. Wood, R. K., Murray, S. K., Offman, S. L., Carter, M.D. 2020. Lynch syndrome screening in endometrial carcinoma: A two-antibody (PMS2/MSH6) immunohistochemistry panel can lead to underdiagnosis of MSH2-deficient tumours. Canadian Journal of Pathology 13(3), 14-25.      

Links